• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYER PHARMA AG ESSURE; TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE Back to Search Results
Model Number ESS305
Device Problems Difficult or Delayed Positioning (1157); Device Dislodged or Dislocated (2923)
Patient Problem Foreign Body In Patient (2687)
Event Type  Injury  
Event Description
This spontaneous case was reported by a physician and describes the occurrence of device dislocation ("metallic foreign body in her abdomen, which appears to be the essure / floating free in her abdominal cavity") in a (b)(6) female patient who had essure inserted for female sterilization.The occurrence of additional non-serious events is detailed below.Other product or product use issues identified: device difficult to use "could not place insert into right tube; apparently it was blocked or just couldn't get it in" in (b)(6) 2015.In (b)(6) 2015, the patient had essure inserted.On an unknown date, the patient experienced device dislocation (seriousness criteria medically significant and intervention required) and adverse event ("she was seen for some other complaint in the er").Essure treatment was not changed.At the time of the report, the device dislocation and adverse event outcome was unknown.The reporter provided no causality assessment for adverse event and device dislocation with essure.The reporter commented: doctor is planning to perform a laparoscopy to remove these things so that it does not perforate her bowel or any other structure because it is definitely floating free in her abdominal cavity.Diagnostic results (normal ranges are provided in parenthesis if available): hysterosalpingogram - in 2016: both tubes occluded on (b)(6) 2017, ct scan done and it showed she had a metallic foreign body in her abdomen, which appears to be the essure.Incident.No lot number or sample available for investigation.There is no evidence that a device-related defect or malfunction caused a death or serious injury.If additional information becomes available it will be provided on a supplemental report.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ESSURE
Type of Device
TRANSCERVICAL CONTRACEPTIVE TUBAL OCCLUSION DEVICE
Manufacturer (Section D)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM  13353
Manufacturer (Section G)
BAYER PHARMA AG
müllerstr. 178
berlin, 13353
GM   13353
Manufacturer Contact
k. shaw lamberson
100 bayer blvd, p.o. box 915
whippany, NJ 07981-0915
MDR Report Key6837574
MDR Text Key84330418
Report Number2951250-2017-03325
Device Sequence Number1
Product Code HHS
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020014
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Reporter Occupation Other
Type of Report Initial
Report Date 09/01/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/01/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model NumberESS305
Was the Report Sent to FDA? No
Date Manufacturer Received08/14/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Age34 YR
-
-